Menu
Back to User profile » Dr Osamu Shirakawa
Papers published by Dr Osamu Shirakawa:
Real-World Treatment Patterns and Adherence to Oral Medication Among Patients with Bipolar Disorders: A Retrospective, Observational Study Using a Healthcare Claims Database
Inoue T, Sano H, Kojima Y, Yamada S, Shirakawa O
Neuropsychiatric Disease and Treatment 2021, 17:821-833
Published Date: 18 March 2021
Prevalence of Comorbid Anxiety Disorders and Their Associated Factors in Patients with Bipolar Disorder or Major Depressive Disorder
Inoue T, Kimura T, Inagaki Y, Shirakawa O
Neuropsychiatric Disease and Treatment 2020, 16:1695-1704
Published Date: 12 July 2020
Discrepancies between self- and observer-rated depression severities in patients with major depressive disorder associated with frequent emotion-oriented coping responses and hopelessness
Tsujimoto E, Tsujii N, Mikawa W, Ono H, Shirakawa O
Neuropsychiatric Disease and Treatment 2018, 14:2331-2336
Published Date: 12 September 2018
Association study of MIF promoter polymorphisms with suicide completers in the Japanese population
Shimmyo N, Hishimoto A, Otsuka I, Okazaki S, Boku S, Mouri K, Horai T, Takahashi M, Ueno Y, Shirakawa O, Sora I
Neuropsychiatric Disease and Treatment 2017, 13:899-908
Published Date: 22 March 2017
Treatment discontinuation and tolerability as a function of dose and titration of duloxetine in the treatment of major depressive disorder
Harada E, Shirakawa O, Satoi Y, Marangell LB, Escobar R
Neuropsychiatric Disease and Treatment 2016, 12:89-97
Published Date: 11 January 2016
Association analysis of the Cadherin13 gene with schizophrenia in the Japanese population
Otsuka I, Watanabe Y, Hishimoto A, Boku S, Mouri K, Shiroiwa K, Okazaki S, Nunokawa A, Shirakawa O, Someya T, Sora I
Neuropsychiatric Disease and Treatment 2015, 11:1381-1393
Published Date: 2 June 2015